Literature DB >> 21157430

The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process.

Pierre Chymkowitch1, Nicolas Le May, Pierre Charneau, Emmanuel Compe, Jean-Marc Egly.   

Abstract

In response to hormonal stimuli, a cascade of hierarchical post-translational modifications of nuclear receptors are required for the correct expression of target genes. Here, we show that the transcription factor TFIIH, via its cdk7 kinase, phosphorylates the androgen receptor (AR) at position AR/S515. Strikingly, this phosphorylation is a key step for an accurate transactivation that includes the cyclic recruitment of the transcription machinery, the MDM2 E3 ligase, the subsequent ubiquitination of AR at the promoter of target genes and its degradation by the proteasome machinery. Impaired phosphorylation disrupts the transactivation, as observed in cells either overexpressing the non-phosphorylated AR/S515A, isolated from xeroderma pigmentosum patient (bearing a mutation in XPD subunit of TFIIH), or in which cdk7 kinase was silenced. Indeed, besides affecting the cyclic recruitment of the transcription machinery, the AR phosphorylation defect favourizes to the recruitment of the E3 ligase CHIP instead of MDM2, at the PSA promoter, that will further attract the proteasome machinery. These observations illustrate how the TFIIH phosphorylation might participate to the transactivation by regulating the nuclear receptors turnover.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157430      PMCID: PMC3034013          DOI: 10.1038/emboj.2010.337

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

Review 2.  Orchestrated response: a symphony of transcription factors for gene control.

Authors:  B Lemon; R Tjian
Journal:  Genes Dev       Date:  2000-10-15       Impact factor: 11.361

Review 3.  Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.

Authors:  James E Cleaver; Ernest T Lam; Ingrid Revet
Journal:  Nat Rev Genet       Date:  2009-10-07       Impact factor: 53.242

Review 4.  No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription.

Authors:  Thomas Kodadek
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

5.  From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator.

Authors:  D K Lee; H O Duan; C Chang
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

6.  Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7.

Authors:  D Chen; T Riedl; E Washbrook; P E Pace; R C Coombes; J M Egly; S Ali
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

7.  Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.

Authors:  Shan Yan; Xuxu Sun; Binggang Xiang; Hui Cang; Xunlei Kang; Yuying Chen; Hui Li; Guiying Shi; Edward T H Yeh; Beilei Wang; Xiangrui Wang; Jing Yi
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

8.  The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.

Authors:  John DaSilva; Daniel Gioeli; Michael J Weber; Sarah J Parsons
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

Review 9.  Androgens and bone.

Authors:  Dirk Vanderschueren; Jemima Gaytant; Steven Boonen; Katrien Venken
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-06       Impact factor: 3.243

Review 10.  Androgen receptor functions in male and female physiology.

Authors:  Takahiro Matsumoto; Hiroko Shiina; Hirotaka Kawano; Takashi Sato; Shigeaki Kato
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-19       Impact factor: 4.292

View more
  62 in total

Review 1.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

2.  Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.

Authors:  William H Lagarde; Amanda J Blackwelder; John T Minges; Andrew T Hnat; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

3.  Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.

Authors:  Shaoyong Chen; Sarah Gulla; Changmeng Cai; Steven P Balk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 4.  TFIIH: when transcription met DNA repair.

Authors:  Emmanuel Compe; Jean-Marc Egly
Journal:  Nat Rev Mol Cell Biol       Date:  2012-05-10       Impact factor: 94.444

5.  The ubiquitin ligase Siah2 is revealed as an accomplice of the androgen receptor in castration resistant prostate cancer.

Authors:  Michael R Freeman
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

6.  The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.

Authors:  Shu-Ting Chen; Maiko Okada; Ryuichiro Nakato; Kosuke Izumi; Masashige Bando; Katsuhiko Shirahige
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

7.  Chromatin Association of Gcn4 Is Limited by Post-translational Modifications Triggered by its DNA-Binding in Saccharomyces cerevisiae.

Authors:  Akhi Akhter; Emanuel Rosonina
Journal:  Genetics       Date:  2016-10-21       Impact factor: 4.562

8.  ARCH domain of XPD, an anchoring platform for CAK that conditions TFIIH DNA repair and transcription activities.

Authors:  Wassim Abdulrahman; Izarn Iltis; Laura Radu; Cathy Braun; Anne Maglott-Roth; Christophe Giraudon; Jean-Marc Egly; Arnaud Poterszman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

10.  Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Authors:  S Sarkar; D L Brautigan; S J Parsons; J M Larner
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.